Heart Failure clinical trials in Minnesota
45 active Heart Failure trials with a site in Minnesota. Describe your situation to see which ones look like a fit.
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
- TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
- Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
- Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
- The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
- A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
- A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
- A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
- Assessment of CCM in HF With Higher Ejection Fraction
- A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
- Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure
- Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
- A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
- The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)
- CAMEO-FONTAN -Dapagliflozin in the Failing Fontan Circulation
- Autologous Induced Pluripotent Stem Cells of Cardiac Lineage for Congenital Heart Disease
- COMPARE-VENT Feasibility Pilot Study
- Treatment of Pulmonary Arterial Hypertension Using the Aria CV Pulmonary Hypertension System
- Left vs Left Randomized Clinical Trial
- Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
- PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
- Alleviant ALLAY-HF Study
- Alleviant ALLAY-HFrEF Study
- Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
- CCM OPEN HF Registry
- A Study of Paramedic HF Management
- Voice Analysis for Monitoring Patients With Heart Failure
- HF2 Registry - Hemodynamic Frontiers in Heart Failure Registry
- Contrast Echocardiography During Exercise to Assess Pulmonary Blood Volume
- Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
- HeartShare: Combining Omics, Deep Phenotyping, and Electronic Health Records for Heart Failure Subtypes and Treatment Targets
- Ultra-High Frequency - Electrocardiogram (UHF-ECG) for the Diagnosis of Ventricular Electrical Dyssynchrony (VED)
- Pulmonary Hypertension in Left Heart Disease
- His Bundle Pacing in Bradycardia and Heart Failure
- Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
- CSP #2025 - Geriatric OUt-of-hospital Randomized MEal Trial in Heart Failure: Veterans Affairs (GOURMET-VA)
- Inspiratory Muscle Training in HFpEF
- A Study to Evaluate Breathing Muscle Training in Cardiac Rehab
- AI-Guided Left Bundle Branch Area Pacing
- Pivotal Trial to Evaluate the Safety and Effectiveness of the P&F TricValve® Transcatheter Bicaval Valve System
- Evaluation of Liver Stiffness Performance, by FibroScan®, to Detect Elevated Central Venous Pressure (CVP)
- Study of JK07 in Patients With Chronic Heart Failure
- A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation
- LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.